Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IDO1 antibody

The Mouse Monoclonal anti-IDO1 antibody has been validated for WB, ELISA, IHC, IF, FACS, IP, FM and MA. It is suitable to detect IDO1 in samples from Mouse. There is 1 publication available.
Rockland
Catalog No. ABIN1043819
Supplier Product No.: 210-301-e58

Quick Overview for IDO1 antibody (ABIN1043819)

Target

See all IDO1 Antibodies
IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))

Reactivity

  • 84
  • 31
  • 16
  • 9
  • 1
  • 1
  • 1
Mouse

Host

  • 78
  • 15
  • 1
  • 1
Mouse

Clonality

  • 69
  • 26
  • 1
Monoclonal

Conjugate

  • 67
  • 5
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This IDO1 antibody is un-conjugated

Application

  • 74
  • 36
  • 36
  • 22
  • 17
  • 16
  • 15
  • 14
  • 11
  • 11
  • 6
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS), Immunoprecipitation (IP), Fluorescence Microscopy (FM), Multiplex Assay (MA)

Clone

2E2-6
  • Supplier Product No.

    210-301-e58

    Supplier

    Rockland

    Purpose

    IDO1 Antibody

    Cross-Reactivity (Details)

    IDO1 antibody is specific for mouse IDO1 protein.

    Characteristics

    Synonyms: mouse anti-IDO1 antibody, Ido, Indo, Indoleamine 2,3-dioxygenase 1, Indoleamine-pyrrole 2,3-dioxygenase, Ido 1, Ido-1, IDO1 antibody, mouse anti-IDO-1 antibody

    Purification

    Anti-IDO1 antibody was purified from ascites fluid by Protein A chromatography followed by extensive dialysis against the buffer stated above.

    Sterility

    Sterile filtered

    Immunogen

    Immunogen: IDO1 antibody was produced in mouse by repeated immunizations with mouse recombinant IDO1 protein followed by hybridoma development.

    Immunogen Type: Recombinant Protein

    Isotype

    IgG1
  • Application Notes

    Flow Cytometry Dilution: 0.5-1x10^6 cells

    Immunohistochemistry Dilution: User Optimized

    Application Note: Anti-IDO1 antibody has been tested for use in ELISA, Western Blot, IF, IHC, and Flow Cytometry. Specific conditions for reactivity should be optimized by the end user.

    Western Blot Dilution: 1:500-1:1500

    Immunoprecipitation Dilution: 10-100 μL

    ELISA Dilution: 1:5000-1:50000

    IF Microscopy Dilution: 1:50-1:100

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.95 mg/mL

    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: None

    Preservative: 0.01 % (w/v) Sodium Azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.

    Expiry Date

    12 months
  • Mellor, Munn: "IDO expression by dendritic cells: tolerance and tryptophan catabolism." in: Nature reviews. Immunology, Vol. 4, Issue 10, pp. 762-74, (2004) (PubMed).

  • Target

    IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))

    Alternative Name

    Ido1

    Background

    Background: Anti-IDO-1 antibody recognizes indoleamine 2, 3-dioxygenase1 (IDO1) is a 41-42 kD intracellular enzyme that catabolizes tryptophan into kynurenine. IDO1 modulates levels of the amino acid tryptophan, which is vital for cell growth, but is also involved in the suppression of the immune response. IDO1 effects on immune suppression are due to decreased tryptophan availability and the generation of tryptophan metabolites, resulting in negative effects on T lymphocytes, including proliferation, function and survival. IDO1 may be involved in the suppression of the immune response to tumors, and blocking the IDO1 pathway may be a potential target for immuno and cancer therapy. IDO1 is expressed in a wide variety of tissues and can be upregulated by interferon gamma and other inflammatory cytokines.

    Gene ID

    15930

    NCBI Accession

    NP_032350

    UniProt

    P28776

    Pathways

    Activated T Cell Proliferation
You are here:
Chat with us!